Literature DB >> 30476563

History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients.

Giovanni Oriolo1, Lison Huet2, Sandra Dexpert2, Cédric Beau3, Damien Forestier3, Patrick Ledaguenel3, Eric Magne3, Rocío Martin-Santos4, Lucile Capuron5.   

Abstract

Obesity is a major public health burden associated with neuropsychiatric comorbidities leading to social and occupational impairment. Given the growing prevalence of both obesity and mental disorders worldwide, understanding the risk factors of obesity-related neuropsychiatric comorbidities is crucial to develop preventive strategies and individualized treatments. Recent findings suggest that adiposity-driven inflammation contributes to neuropsychiatric comorbidities in obesity. However, not all obese subjects afflicted with chronic inflammation develop neuropsychiatric symptoms, suggesting additional risk factors. The aim of this study was to investigate the impact of personal history of major depressive disorder (MDD) on obesity-related inflammation and neuropsychiatric symptoms, and their relationship. A case-control study was conducted comparing 66 obese patients (body mass index > 35 kg/m2) and 22 healthy non-obese participants, free of any current neuropsychiatric diseases including MDD. Neuropsychiatric symptoms were assessed using the Neurotoxicity Rating Scale (NRS). Sociodemographic and clinical variables were gathered and blood was collected for the measurement of serum levels of high-sensitivity C-reactive protein (hs-CRP). Multiple regression analyses were performed to assess the contribution of obesity and personal history of MDD to clinical outcomes and inflammatory status in study participants. Hs-CRP levels as well as NRS scores were significantly increased in the obese group. Overall, personal history of depression accounted for increased NRS scores but no significant association was found with inflammatory status. In addition, history of depression did not significantly modulate the relationship of obesity-related inflammation with NRS scores. Interestingly, obese individuals with history of recurrent MDD (n = 13) exhibited higher scores in the cognitive and sickness symptoms dimensions of the NRS compared to obese subjects with history of one depressive episode only. Findings indicate that history of depression contributes to neuropsychiatric symptoms, but not to systemic inflammation, in obese subjects free of current depressive episode. These results provide relevant information on the risk factors that may help identify obese subjects with increased risk of neuropsychiatric comorbidity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Inflammation; Major depressive disorder (MDD); Neuropsychiatric symptoms; Obesity; Vulnerability

Mesh:

Substances:

Year:  2018        PMID: 30476563     DOI: 10.1016/j.bbi.2018.11.312

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  2 in total

1.  High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.

Authors:  Ricard Navinés; Giovanni Oriolo; Igor Horrillo; Myriam Cavero; Bruno Aouizerate; Martin Schaefer; Lucile Capuron; J Javier Meana; Rocio Martin-Santos
Journal:  Int J Neuropsychopharmacol       Date:  2022-06-21       Impact factor: 5.678

2.  Association between fasting blood glucose and thyroid stimulating hormones and suicidal tendency and disease severity in patients with major depressive disorder.

Authors:  Weiting Liu; Zezhen Wu; Min Sun; Shuo Zhang; Juan Yuan; Dan Zhu; Guimimg Yan; Kaijian Hou
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.